Pharmanex (NuSkin), Provo, UT, released results of a study, which found that Tegreen 97 enhanced blood sugar control, body fat burning properties and weight loss benefits in an experimental setting of metabolic “Syndrome X” subjects. The findings of the study were presented at the American Heart Association’s Sixth Annual Conference.

The purpose of this study was to examine the effects of Tegreen 97 in enhancing insulin sensitivity and improving glucose-lipid metabolism. In addition, the research examined the effects of the proprietary green tea supplement in lowering body weight and the weight of abdominal fat, as well as inhibiting angiogenesis (a key pathological process in the development of abnormal cells), which is hypothesized to play an important role in development of obesity.

The results of the study showed Tegreen 97 enhanced insulin sensitivity, improved glucose-lipid metabolism, increased fat burning and decreased body fat percentage, and lowered body weight associated with inhibited angiogenesis.

Tegreen 97 is a proprietary, decaffeinated green tea extract standardized to 97% polyphenols—two-thirds of which are catechins. Each capsule of Tegreen 97 contains the same amount of catechins found in seven cups of traditionally brewed green tea.